What Is Bufo? A Trauma-Informed Guide to 5-MeO-DMT

Of all the medicines we hold at Pura Vida Collective, few are spoken about with more awe, or more misunderstanding, than Bufo. I want to explain it the same way I would to someone sitting across from me on a discovery call: plainly, reverently, and with safety at the center.

What it is

Bufo is the common name for a ceremonial medicine associated with the Sonoran Desert toad (Incilius alvarius), whose defensive secretion contains 5-MeO-DMT, a powerful and very fast-acting psychedelic compound. 5-MeO-DMT is also found in some plants and can be made in a laboratory. At Pura Vida Collective, we serve toad-derived Bufo rather than a synthetic version because, for us, the relationship with the toad and the spirit of the medicine are part of the ceremony itself.

Where a psilocybin journey unfolds over hours with imagery and narrative, a Bufo ceremony is usually brief and can feel total: minutes on the clock, while the experience itself may feel outside of time. People often reach for words like dissolution, light, home, or oneness because ordinary language can feel too small for it.

What a ceremony is like

No two Bufo experiences are the same, even for the same person. The medicine is usually inhaled, its effects begin within seconds, and a single dose can last anywhere from about fifteen to forty-five minutes.

The closest words I have for it are meeting your soul. The ego, with its roles, stories and constant commentary, falls away completely. Researchers describe psychedelic states as quieting the brain’s default mode network, the system behind our running story of who we are, and with Bufo that quieting can be total. What remains is not a vision or a narrative but the essence of existence itself: pure being, without the self that usually stands in the way.

People return from it in many ways: tender, tearful, laughing, astonished, or simply quiet. Many describe feeling clear or energized afterward, as though they have remembered something essential rather than learned something new.

Because awareness of the body can disappear entirely, a person in ceremony cannot look after themselves during those minutes. They may move, cry out or purge. That is why every Bufo ceremony needs a trained facilitator physically present throughout, a safe place to lie down, and a plan for anything that arises.

What research shows so far

Research on 5-MeO-DMT is young, and it is worth being precise about what it does and does not show.

• Surveys of people who have used it. In a Johns Hopkins survey of 362 adults who had used 5-MeO-DMT in ceremonial group settings, about 80 percent reported improvements in anxiety or depression afterward. The researchers were clear that self-reported surveys cannot establish cause, and that the work is in its infancy.
• An early clinical trial. A small 2023 trial of a vaporized, laboratory-made 5-MeO-DMT in 16 people with treatment-resistant depression reported rapid improvement in many participants and no serious adverse events. It was open-label, with no placebo group, so it points to a direction for research rather than proof.

What we can say honestly: early findings are striking, and larger, controlled studies are needed. What we do not say: that Bufo treats or cures any condition.

The real risks

Bufo is powerful, and its risks are real. Careful screening and facilitation reduce avoidable harm; they do not remove it.

• Dangerous combinations. 5-MeO-DMT can interact dangerously with certain medications, including some antidepressants, and must never be combined with MAO-inhibiting substances such as those in ayahuasca or Syrian Rue. Deaths have been associated with this kind of combination.
• Heart and blood pressure. The experience can raise heart rate and blood pressure, so cardiovascular history matters.
• Mental health history. It may not be appropriate for people with a personal or family history of psychosis or bipolar disorder.
• The minutes of total dissolution. Without a trained sitter, falls, choking during purging and panic are genuine dangers.
• After the ceremony. Some people experience brief returns of the altered state or emotional intensity in the days that follow. Integration support matters.

This is why no responsible facilitator treats Bufo casually, and why screening is a real conversation, not a form.

Why reverence matters

Bufo is not simply a stronger version of another medicine. It is its own experience, and it asks for a different level of care. In my experience, it is the most direct doorway we hold. Precisely because it can be so total, everything around it matters: screening, preparation, the readiness of the nervous system, the skill of the facilitator, the quiet of the space, and the integration that follows. This is not a medicine I believe should ever be casual or rushed. The container matters as much as the ceremony itself.

Honoring the toad

Reverence extends to the toad itself. The Sonoran Desert toad lives in a limited range across the southwestern United States and northwestern Mexico, and growing global demand for its medicine has raised real concern for wild populations. Choosing to work with toad-derived Bufo carries a responsibility with it. For us, sourcing, the wellbeing of the toad, and respect for the land it comes from belong in the same conversation as the ceremony itself.

How we hold it

At REVIVE, no one is simply scheduled for Bufo. Each guest’s transformative path is individually curated in private consultation after medical and psychological screening, and for some people this ceremony may belong to a different season of their life. That is not a rejection. It is respect for both the person and the medicine. Sovereignty matters at every threshold: you will never be pressured to go deeper than you choose, and you will never be left alone in the experience.

The people who meet this medicine rarely come back describing what they saw. They come back describing what they remembered.

Sources: Davis et al., 5-MeO-DMT used in a naturalistic group setting is associated with unintended improvements in depression and anxiety, The American Journal of Drug and Alcohol Abuse, 2019 · Reckweg et al., A phase 1/2 trial of a vaporized 5-MeO-DMT formulation (GH001) in treatment-resistant depression, Frontiers in Psychiatry, 2023 · National Geographic, The Sonoran Desert toad can get you high. Poachers have taken notice.